Maha approves Rs 300 crore high-energy medical cyclotron facility in Nagpur Divyani Paul17 Jun 2026 4:30 PM ISTNagpur- The Maharashtra Cabinet on Tuesday approved the establishment of a High-Energy Medical Cyclotron Project (HEMCP) in Nagpur to strengthen...
KGMU to transfer Asadhya Yojana funds directly to patients after Rs 2.5 crore scam Rumela De Sarkar16 Jun 2026 11:23 AM ISTLucknow: In a significant policy shift aimed at improving transparency and preventing financial irregularities, King George’s Medical University...
Ipca Labs Partners BRL to Develop Next-Generation Subcutaneous Biologics for Cancer, Autoimmune Diseases sheeba farhat13 Jun 2026 11:00 AM ISTMumbai: Ipca Laboratories Ltd. has entered into a definitive global licensing agreement with Bhami Research Laboratory Pvt. Ltd. (BRL), gaining access...
Alembic Pharma Secures USFDA Tentative Nod for Generic Vitrakvi, Eyes 180-Day Exclusivity sheeba farhat11 Jun 2026 6:22 PM ISTNew Delhi: Alembic Pharmaceuticals Limited (Alembic) has announced that it has received tentative approval from the US Food & Drug Administration...
Kiran Shaw Backed Cancer Therapy Startup Immuneel Secures Rs 100 Crore in Series B Funding Parthika Patel9 Jun 2026 9:16 PM ISTNew Delhi: Immuneel Therapeutics, a Bengaluru-based cell and gene therapy company backed by investors including Eight Roads Ventures and co-founded by...
Naprod Seeks Higher NPPA Ceiling Prices for Cisplatin, Carboplatin Amid Cancer Drug Supply Crunch Susmita Roy8 Jun 2026 11:00 PM ISTNew Delhi: Oncology drug manufacturer Naprod Life Sciences has approached the National Pharmaceutical Pricing Authority (NPPA) seeking an upward...
Natco, Lupin Secure USFDA Nod for Generic Cancer Drug Eribulin Mesylate Injection sheeba farhat3 Jun 2026 7:14 PM ISTNew Delhi: NATCO Pharma Limited and its alliance partner Lupin Limited has announced the approval from the United States Food and Drug Administration...
Sun Pharma's UNLOXCYT Shows Durable 50% Response in Advanced Skin Cancer Study Parthika Patel27 May 2026 10:18 PM ISTNew Delhi: Sun Pharmaceutical Industries has announced that it will present updated long-term follow-up data from the pivotal CK-301-101 trial...
Moderna, Merck Cancer Vaccine Combo Achieves 92% Survival Rate in Melanoma Trial MD Bureau26 May 2026 5:58 PM ISTBengaluru: Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body by 59% after...
CDSCO Approves Astellas' PADCEV-Pembrolizumab Combo for Advanced Bladder Cancer sheeba farhat22 May 2026 11:02 PM ISTNew Delhi: Astellas Pharma India has announced that the Central Drugs Standard Control Organisation (CDSCO) has approved PADCEV (enfortumab vedotin)...
CDSCO Approves Aurobindo CuraTeQ's Bevacizumab Biosimilar Bevqolva for Cancer Treatment Parthika Patel17 May 2026 10:22 PM ISTNew Delhi: Aurobindo Pharma on Friday announced that its wholly owned subsidiary CuraTeQ Biologics Pvt Ltd has received marketing authorisation from...
Aurobindo Arm CuraTeQ Secures Health Canada Nod for Cancer Biosimilar Bevqolva sheeba farhat4 May 2026 11:00 PM ISTNew Delhi: Aurobindo Pharma on Friday said its arm CuraTeQ Biologics has received a compliance notice from Health Canada's Biologics and...
